BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 33365314)

  • 1. Analysis of Cyclin-Dependent Kinase 1 as an Independent Prognostic Factor for Gastric Cancer Based on Statistical Methods.
    Zhang X; Ma H; Zou Q; Wu J
    Front Cell Dev Biol; 2020; 8():620164. PubMed ID: 33365314
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of cuproptosis-related subtypes, construction of a prognosis model, and tumor microenvironment landscape in gastric cancer.
    Wang J; Qin D; Tao Z; Wang B; Xie Y; Wang Y; Li B; Cao J; Qiao X; Zhong S; Hu X
    Front Immunol; 2022; 13():1056932. PubMed ID: 36479114
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Upregulation of FGD6 Predicts Poor Prognosis in Gastric Cancer.
    Zeng J; Li M; Shi H; Guo J
    Front Med (Lausanne); 2021; 8():672595. PubMed ID: 34291059
    [No Abstract]   [Full Text] [Related]  

  • 4. LAMC1 is a Novel Prognostic Factor and a Potential Therapeutic Target in Gastric Cancer.
    Xi D; Jia Q; Liu X; Zhang L; Xu B; Ma Z; Ma Y; Yu Y; Zhang F; Chen H
    Int J Gen Med; 2022; 15():3183-3198. PubMed ID: 35342300
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HTRA3 Is a Prognostic Biomarker and Associated With Immune Infiltrates in Gastric Cancer.
    Ji C; Sun LS; Xing F; Niu N; Gao HL; Dai JW; Zhou N; Jiang BC
    Front Oncol; 2020; 10():603480. PubMed ID: 33425760
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overexpression of DGKI in Gastric Cancer Predicts Poor Prognosis.
    Huang C; Zhao J; Luo C; Zhu Z
    Front Med (Lausanne); 2020; 7():320. PubMed ID: 32733904
    [No Abstract]   [Full Text] [Related]  

  • 7. Overexpression of GUCY1A2 Correlates With Poor Prognosis in Gastric Cancer Patients.
    Li X; Chen X; Hu X; Shen Y; Xu R; Wu L; Shen X
    Front Oncol; 2021; 11():632172. PubMed ID: 34113559
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of LOX Suggests Poor Prognosis in Gastric Cancer.
    Zhu J; Luo C; Zhao J; Zhu X; Lin K; Bu F; Yu Z; Zou F; Zhu Z
    Front Med (Lausanne); 2021; 8():718986. PubMed ID: 34595188
    [No Abstract]   [Full Text] [Related]  

  • 9. Identification of
    Wang Y; Fang Y; Zhao F; Gu J; Lv X; Xu R; Zhang B; Fang Z; Li Y
    Front Genet; 2022; 13():810292. PubMed ID: 35368661
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High Prolyl 4-Hydroxylase Subunit Alpha 3 Expression as an Independent Prognostic Biomarker and Correlated With Immune Infiltration in Gastric Cancer.
    Niu X; Ren L; Wang S; Gao D; Ma M; Hu A; Qi H; Zhang S
    Front Genet; 2022; 13():952335. PubMed ID: 35846138
    [No Abstract]   [Full Text] [Related]  

  • 11. A novel copper-induced cell death-related lncRNA prognostic signature associated with immune infiltration and clinical value in gastric cancer.
    Wang L; Xiao K; Dong Z; Meng T; Cheng X; Xu Y
    J Cancer Res Clin Oncol; 2023 Sep; 149(12):10543-10559. PubMed ID: 37291405
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A nomogram model based on the number of examined lymph nodes-related signature to predict prognosis and guide clinical therapy in gastric cancer.
    Li H; Lin D; Yu Z; Li H; Zhao S; Hainisayimu T; Liu L; Wang K
    Front Immunol; 2022; 13():947802. PubMed ID: 36405735
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification and validation of the prognostic value of cyclic GMP-AMP synthase-stimulator of interferon (cGAS-STING) related genes in gastric cancer.
    Yang KS; Xu CQ; Lv J
    Bioengineered; 2021 Dec; 12(1):1238-1250. PubMed ID: 33843442
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High
    Yuan L; Hu C; Yu P; Bao Z; Xia Y; Zhang B; Wang Y
    Ann Transl Med; 2022 Sep; 10(18):990. PubMed ID: 36267769
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LUM Expression and Its Prognostic Significance in Gastric Cancer.
    Chen X; Li X; Hu X; Jiang F; Shen Y; Xu R; Wu L; Wei P; Shen X
    Front Oncol; 2020; 10():605. PubMed ID: 32500021
    [No Abstract]   [Full Text] [Related]  

  • 16. Aberrant brain-expressed X-linked 4 (BEX4) expression is a novel prognostic biomarker in gastric cancer.
    Zhu C; Xiao D
    Medicine (Baltimore); 2020 Nov; 99(47):e23133. PubMed ID: 33217815
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High expression of TMEM200A is associated with a poor prognosis and immune infiltration in gastric cancer.
    Deng H; Li T; Wei F; Han W; Xu X; Zhang Y
    Pathol Oncol Res; 2023; 29():1610893. PubMed ID: 36741965
    [No Abstract]   [Full Text] [Related]  

  • 18. CTHRC1 Is Associated With Immune Escape and Poor Prognosis in Gastric Cancer.
    Hu Y; Huang L; Zhao K; Li Y; Givens NT; Heslin AJ; Deng Z; Cao L; Fang Y
    Anticancer Res; 2023 Jan; 43(1):115-126. PubMed ID: 36585164
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low KCNQ1 expression is associated with unfavorable outcome and metabolism of gastric cancer.
    Yang Z; Duan S; Hu X; Dai B; Bao G; Xin W
    Am J Transl Res; 2023; 15(6):3992-4005. PubMed ID: 37434821
    [TBL] [Abstract][Full Text] [Related]  

  • 20. hsa_circ_0060975 is highly expressed and predicts a poor prognosis in gastric cancer.
    Xu P; Xu X; Zhang L; Li Z; Qiang J; Yao J; Xu A
    Oncol Lett; 2021 Aug; 22(2):619. PubMed ID: 34257727
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.